Regulatory Post Marketing Surveillance (rPMS) Study of Xultophy® (Insulin Degludec/Liraglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
Clinical trial NCT04952779 · COMPLETED
Trial details
- NCT number
- NCT04952779
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-06-02
- Primary completion
- 2024-12-15
- Enrollment
- 750
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.